nodes	percent_of_prediction	percent_of_DWPC	metapath
Tipranavir—CYP2D6—Parkinson's disease	0.988	1	CbGaD
Tipranavir—Cinacalcet—CYP2D6—Parkinson's disease	0.00235	1	CrCbGaD
Tipranavir—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.000698	0.0746	CbGpPWpGaD
Tipranavir—CYP2C19—CYP2E1 reactions—CYP2D6—Parkinson's disease	0.000324	0.0347	CbGpPWpGaD
Tipranavir—CYP2C19—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000297	0.0317	CbGpPWpGaD
Tipranavir—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000275	0.0294	CbGpPWpGaD
Tipranavir—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000273	0.0292	CbGpPWpGaD
Tipranavir—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.000252	0.0269	CbGpPWpGaD
Tipranavir—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000202	0.0216	CbGpPWpGaD
Tipranavir—CYP2C19—Xenobiotics—CYP2D6—Parkinson's disease	0.000201	0.0215	CbGpPWpGaD
Tipranavir—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.000194	0.0207	CbGpPWpGaD
Tipranavir—CYP2C19—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000193	0.0207	CbGpPWpGaD
Tipranavir—CYP2C19—Xenobiotics—CYP2E1—Parkinson's disease	0.000184	0.0197	CbGpPWpGaD
Tipranavir—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00018	0.0192	CbGpPWpGaD
Tipranavir—CYP2C19—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000177	0.0189	CbGpPWpGaD
Tipranavir—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000169	0.0181	CbGpPWpGaD
Tipranavir—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000163	0.0174	CbGpPWpGaD
Tipranavir—CYP2C19—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.000149	0.016	CbGpPWpGaD
Tipranavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000145	0.0155	CbGpPWpGaD
Tipranavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000132	0.0141	CbGpPWpGaD
Tipranavir—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000121	0.0129	CbGpPWpGaD
Tipranavir—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000119	0.0127	CbGpPWpGaD
Tipranavir—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000116	0.0124	CbGpPWpGaD
Tipranavir—CYP2C19—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000112	0.012	CbGpPWpGaD
Tipranavir—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.000111	0.0118	CbGpPWpGaD
Tipranavir—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000106	0.0114	CbGpPWpGaD
Tipranavir—CYP2C19—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000105	0.0112	CbGpPWpGaD
Tipranavir—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000103	0.0111	CbGpPWpGaD
Tipranavir—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	9.97e-05	0.0107	CbGpPWpGaD
Tipranavir—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	9.93e-05	0.0106	CbGpPWpGaD
Tipranavir—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	9.86e-05	0.0105	CbGpPWpGaD
Tipranavir—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	9.83e-05	0.0105	CbGpPWpGaD
Tipranavir—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	9.63e-05	0.0103	CbGpPWpGaD
Tipranavir—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	9.12e-05	0.00975	CbGpPWpGaD
Tipranavir—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	9.11e-05	0.00973	CbGpPWpGaD
Tipranavir—CYP2C19—Melatonin metabolism and effects—APOE—Parkinson's disease	8.52e-05	0.00911	CbGpPWpGaD
Tipranavir—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	8.38e-05	0.00895	CbGpPWpGaD
Tipranavir—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	8.36e-05	0.00893	CbGpPWpGaD
Tipranavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	8.35e-05	0.00892	CbGpPWpGaD
Tipranavir—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	8.24e-05	0.00881	CbGpPWpGaD
Tipranavir—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	7.83e-05	0.00837	CbGpPWpGaD
Tipranavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	7.64e-05	0.00816	CbGpPWpGaD
Tipranavir—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	7.54e-05	0.00806	CbGpPWpGaD
Tipranavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	7.23e-05	0.00773	CbGpPWpGaD
Tipranavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	7.02e-05	0.00751	CbGpPWpGaD
Tipranavir—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	6.93e-05	0.00741	CbGpPWpGaD
Tipranavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	6.77e-05	0.00723	CbGpPWpGaD
Tipranavir—CYP2C19—Arachidonic acid metabolism—GPX1—Parkinson's disease	6.41e-05	0.00685	CbGpPWpGaD
Tipranavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	6.19e-05	0.00662	CbGpPWpGaD
Tipranavir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	5.93e-05	0.00634	CbGpPWpGaD
Tipranavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	5.69e-05	0.00609	CbGpPWpGaD
Tipranavir—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	5.68e-05	0.00607	CbGpPWpGaD
Tipranavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	5.65e-05	0.00604	CbGpPWpGaD
Tipranavir—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	5.48e-05	0.00585	CbGpPWpGaD
Tipranavir—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	5.43e-05	0.0058	CbGpPWpGaD
Tipranavir—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	5.35e-05	0.00572	CbGpPWpGaD
Tipranavir—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	5.09e-05	0.00544	CbGpPWpGaD
Tipranavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	5.02e-05	0.00537	CbGpPWpGaD
Tipranavir—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	4.99e-05	0.00534	CbGpPWpGaD
Tipranavir—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	4.95e-05	0.0053	CbGpPWpGaD
Tipranavir—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	4.92e-05	0.00526	CbGpPWpGaD
Tipranavir—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	4.84e-05	0.00517	CbGpPWpGaD
Tipranavir—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	4.68e-05	0.00501	CbGpPWpGaD
Tipranavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	4.59e-05	0.00491	CbGpPWpGaD
Tipranavir—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	4.53e-05	0.00484	CbGpPWpGaD
Tipranavir—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	4.45e-05	0.00476	CbGpPWpGaD
Tipranavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	4.07e-05	0.00435	CbGpPWpGaD
Tipranavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	3.72e-05	0.00398	CbGpPWpGaD
Tipranavir—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	3.6e-05	0.00384	CbGpPWpGaD
Tipranavir—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	3.55e-05	0.00379	CbGpPWpGaD
Tipranavir—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	3.29e-05	0.00351	CbGpPWpGaD
Tipranavir—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	3.26e-05	0.00349	CbGpPWpGaD
Tipranavir—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.24e-05	0.00347	CbGpPWpGaD
Tipranavir—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	3.22e-05	0.00344	CbGpPWpGaD
Tipranavir—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	3.06e-05	0.00327	CbGpPWpGaD
Tipranavir—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	3.02e-05	0.00323	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	3.01e-05	0.00321	CbGpPWpGaD
Tipranavir—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	2.98e-05	0.00319	CbGpPWpGaD
Tipranavir—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	2.91e-05	0.00311	CbGpPWpGaD
Tipranavir—CYP2C19—Biological oxidations—COMT—Parkinson's disease	2.72e-05	0.00291	CbGpPWpGaD
Tipranavir—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	2.71e-05	0.0029	CbGpPWpGaD
Tipranavir—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	2.71e-05	0.00289	CbGpPWpGaD
Tipranavir—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	2.69e-05	0.00287	CbGpPWpGaD
Tipranavir—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	2.67e-05	0.00286	CbGpPWpGaD
Tipranavir—CYP2D6—Biological oxidations—COMT—Parkinson's disease	2.51e-05	0.00268	CbGpPWpGaD
Tipranavir—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	2.49e-05	0.00267	CbGpPWpGaD
Tipranavir—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	2.49e-05	0.00266	CbGpPWpGaD
Tipranavir—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	2.49e-05	0.00266	CbGpPWpGaD
Tipranavir—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	2.47e-05	0.00264	CbGpPWpGaD
Tipranavir—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	2.46e-05	0.00263	CbGpPWpGaD
Tipranavir—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	2.46e-05	0.00263	CbGpPWpGaD
Tipranavir—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	2.29e-05	0.00245	CbGpPWpGaD
Tipranavir—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	2.26e-05	0.00242	CbGpPWpGaD
Tipranavir—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	2.16e-05	0.00231	CbGpPWpGaD
Tipranavir—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	2.13e-05	0.00228	CbGpPWpGaD
Tipranavir—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	1.98e-05	0.00211	CbGpPWpGaD
Tipranavir—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	1.95e-05	0.00208	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	1.88e-05	0.00201	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—ND3—Parkinson's disease	1.77e-05	0.00189	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—MCCC1—Parkinson's disease	1.77e-05	0.00189	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—TALDO1—Parkinson's disease	1.66e-05	0.00178	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—OMD—Parkinson's disease	1.66e-05	0.00178	CbGpPWpGaD
Tipranavir—CYP3A4—Biological oxidations—COMT—Parkinson's disease	1.64e-05	0.00175	CbGpPWpGaD
Tipranavir—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	1.63e-05	0.00174	CbGpPWpGaD
Tipranavir—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	1.63e-05	0.00174	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—ND3—Parkinson's disease	1.63e-05	0.00174	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—MCCC1—Parkinson's disease	1.63e-05	0.00174	CbGpPWpGaD
Tipranavir—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	1.62e-05	0.00173	CbGpPWpGaD
Tipranavir—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	1.61e-05	0.00172	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	1.57e-05	0.00168	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—TALDO1—Parkinson's disease	1.53e-05	0.00163	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—OMD—Parkinson's disease	1.53e-05	0.00163	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—GCH1—Parkinson's disease	1.5e-05	0.00161	CbGpPWpGaD
Tipranavir—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	1.5e-05	0.0016	CbGpPWpGaD
Tipranavir—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	1.48e-05	0.00158	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	1.45e-05	0.00155	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—GCH1—Parkinson's disease	1.38e-05	0.00148	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.36e-05	0.00145	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—FBP1—Parkinson's disease	1.34e-05	0.00143	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—GBA—Parkinson's disease	1.34e-05	0.00143	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—DBH—Parkinson's disease	1.34e-05	0.00143	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.23e-05	0.00132	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—DBH—Parkinson's disease	1.23e-05	0.00132	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—GBA—Parkinson's disease	1.23e-05	0.00132	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—ND3—Parkinson's disease	1.06e-05	0.00114	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.06e-05	0.00114	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—OMD—Parkinson's disease	9.99e-06	0.00107	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—TALDO1—Parkinson's disease	9.99e-06	0.00107	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—DDC—Parkinson's disease	9.83e-06	0.00105	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	9.47e-06	0.00101	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—GSTA4—Parkinson's disease	9.28e-06	0.000992	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	9.16e-06	0.00098	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—DDC—Parkinson's disease	9.04e-06	0.000966	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—GCH1—Parkinson's disease	9.03e-06	0.000966	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—GSTA4—Parkinson's disease	8.54e-06	0.000913	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	8.36e-06	0.000893	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—MAOB—Parkinson's disease	8.27e-06	0.000884	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—GBA—Parkinson's disease	8.05e-06	0.000861	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—FBP1—Parkinson's disease	8.05e-06	0.000861	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—DBH—Parkinson's disease	8.05e-06	0.000861	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.87e-06	0.000842	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	7.69e-06	0.000822	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—MAOB—Parkinson's disease	7.61e-06	0.000813	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	6.15e-06	0.000657	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—CTGF—Parkinson's disease	6.04e-06	0.000645	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—DDC—Parkinson's disease	5.91e-06	0.000632	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	5.62e-06	0.000601	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—GSTA4—Parkinson's disease	5.58e-06	0.000597	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—NQO1—Parkinson's disease	5.56e-06	0.000594	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—CTGF—Parkinson's disease	5.55e-06	0.000593	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—TH—Parkinson's disease	5.48e-06	0.000586	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—CYCS—Parkinson's disease	5.26e-06	0.000562	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	5.17e-06	0.000553	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—NQO1—Parkinson's disease	5.11e-06	0.000547	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—TH—Parkinson's disease	5.04e-06	0.000539	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	5.03e-06	0.000537	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.98e-06	0.000532	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—CYCS—Parkinson's disease	4.84e-06	0.000517	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—COMT—Parkinson's disease	4.66e-06	0.000498	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—GSTP1—Parkinson's disease	4.64e-06	0.000496	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—MAOA—Parkinson's disease	4.63e-06	0.000495	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—HMOX1—Parkinson's disease	4.57e-06	0.000489	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—ABCB1—Parkinson's disease	4.39e-06	0.000469	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—COMT—Parkinson's disease	4.29e-06	0.000458	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.27e-06	0.000456	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—GSTM1—Parkinson's disease	4.26e-06	0.000456	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.26e-06	0.000455	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.21e-06	0.00045	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—GPX1—Parkinson's disease	4.08e-06	0.000436	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—ABCB1—Parkinson's disease	4.04e-06	0.000432	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.92e-06	0.000419	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—MTHFR—Parkinson's disease	3.77e-06	0.000403	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.75e-06	0.000401	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.7e-06	0.000395	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.63e-06	0.000388	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—APOE—Parkinson's disease	3.51e-06	0.000375	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.46e-06	0.00037	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.38e-06	0.000361	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.34e-06	0.000357	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—TH—Parkinson's disease	3.3e-06	0.000352	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—APOE—Parkinson's disease	3.23e-06	0.000345	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.16e-06	0.000338	CbGpPWpGaD
Tipranavir—CYP2C19—Metabolism—INS—Parkinson's disease	3e-06	0.00032	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—COMT—Parkinson's disease	2.8e-06	0.0003	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.79e-06	0.000298	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.78e-06	0.000297	CbGpPWpGaD
Tipranavir—CYP2D6—Metabolism—INS—Parkinson's disease	2.76e-06	0.000295	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.75e-06	0.000294	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.64e-06	0.000282	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.56e-06	0.000274	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.45e-06	0.000262	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.27e-06	0.000242	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—APOE—Parkinson's disease	2.11e-06	0.000225	CbGpPWpGaD
Tipranavir—CYP3A4—Metabolism—INS—Parkinson's disease	1.8e-06	0.000193	CbGpPWpGaD
